相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC
Marzia Del Re et al.
BRITISH JOURNAL OF CANCER (2018)
RNA Profiles of Circulating Tumor Cells and Extracellular Vesicles for Therapy Stratification of Metastatic Breast Cancer Patients
Corinna Keup et al.
CLINICAL CHEMISTRY (2018)
Antibody Based EpCAM Targeted Therapy of Cancer, Review and Update
Shirin Eyvazil et al.
CURRENT CANCER DRUG TARGETS (2018)
Cancer cells copy migratory behavior and exchange signaling networks via extracellular vesicles
Sander C. Steenbeek et al.
EMBO JOURNAL (2018)
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Gang Chen et al.
NATURE (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma
Priyanka Sharma et al.
JOURNAL OF EXTRACELLULAR VESICLES (2018)
Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients
Marie-Nicole Theodoraki et al.
CLINICAL CANCER RESEARCH (2018)
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Achim Rittmeyer et al.
LANCET (2017)
Current approaches for avoiding the limitations of circulating tumor cells detection methods-implications for diagnosis and treatment of patients with solid tumors
Artur Kowalik et al.
TRANSLATIONAL RESEARCH (2017)
Characterization of exosomes derived from ovarian cancer cells and normal ovarian epithelial cells by nanoparticle tracking analysis
Wei Zhang et al.
TUMOR BIOLOGY (2016)
A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage
Colette Dezutter-Dambuyant et al.
ONCOIMMUNOLOGY (2016)
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
Annette Becker et al.
CANCER CELL (2016)
Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer
Naoki Takahashi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Exosomal proteins as prognostic biomarkers in non-small cell lung cancer
B. Sandfeld-Paulsen et al.
MOLECULAR ONCOLOGY (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
In Vivo Imaging Reveals Extracellular Vesicle-Mediated Phenocopying of Metastatic Behavior
Anoek Zomer et al.
CELL (2015)
A resource for cell line authentication, annotation and quality control
Mamie Yu et al.
NATURE (2015)
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Bruno Costa-Silva et al.
NATURE CELL BIOLOGY (2015)
The detection of EpCAM+ and EpCAM- circulating tumor cells
Sanne de Wit et al.
SCIENTIFIC REPORTS (2015)
EVpedia: a community web portal for extracellular vesicles research
Dae-Kyum Kim et al.
BIOINFORMATICS (2015)
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial
D. Rossille et al.
LEUKEMIA (2014)
Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance
Xin Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
PD-L1 Expression in Triple-Negative Breast Cancer
Elizabeth A. Mittendorf et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Blood/plasma secretome and microvesicles
Jameel M. Inal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2013)
Two Distinct Populations of Exosomes Are Released from LIM1863 Colon Carcinoma Cell-derived Organoids
Bow J. Tauro et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components
Hong Ji et al.
PROTEOMICS (2013)
Blood Soluble PD-L1 Protein In Aggressive Diffuse Large B-Cell Lymphoma I pacts patient's Overall Survival
Thierry Fest et al.
BLOOD (2013)
Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines
Agnieszka Martowicz et al.
BMC CANCER (2012)
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Hector Peinado et al.
NATURE MEDICINE (2012)
Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes
Claire Corcoran et al.
PLOS ONE (2012)
Identification of a Soluble Form of B7-H1 That Retains Immunosuppressive Activity and Is Associated with Aggressive Renal Cell Carcinoma
Xavier Frigola et al.
CLINICAL CANCER RESEARCH (2011)
High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients
Mariantonia Logozzi et al.
PLOS ONE (2009)
ExoCarta: A compendium of exosomal proteins and RNA
Suresh Mathivanan et al.
PROTEOMICS (2009)
Human tumor-derived exosomes selectively impair lymphocyte responses to interieukin-2
Aled Clayton et al.
CANCER RESEARCH (2007)
Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis
AJ Abusamra et al.
BLOOD CELLS MOLECULES AND DISEASES (2005)
Identification and proteomic profiling of exosomes in human urine
T Pisitkun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Expression of programmed death 1 ligands by murine T cells and APC
T Yamazaki et al.
JOURNAL OF IMMUNOLOGY (2002)
Malignant effusions and immunogenic tumour-derived exosomes
F Andre et al.
LANCET (2002)
B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function
H Tamura et al.
BLOOD (2001)
Ep-CAM overexpression in breast cancer as a predictor of survival
G Gastl et al.
LANCET (2000)
分享论文
